Rose Edmunds lives in Brighton with her husband David. She gained a degree in mathematics at the University of Sussex and a PhD from Cardiff University, before qualifying as a chartered accountant and embarking on a successful career advising entrepreneurial businesses together with their owners. She worked for Arthur Andersen and Grant Thornton, before being headhunted to join Deloitte as a partner.
After more than 20 years in the business she jumped off the corporate hamster wheel and now writes thrillers with a strong ethical theme. Her writing draws heavily on her considerable insight into business world and in particular the uncomfortable conflict between capitalism and humanity.
Rose’s debut thriller, Never Say Sorry, was about a Big Pharma conspiracy to suppress a cancer cure. Since then, she has been working on the Crazy Amy thriller series—an ambitious project which will follow brilliant but unstable Amy Robinson on her journey from senior finance executive to who knows where…
Currently three books have been released. In the first, CONCEALMENT, Amy’s fragile equilibrium is shattered when a junior colleague is murdered. She suspects her bully-boy boss Ed may be implicated, but is her paranoia working overtime? Described by Bestthrillers.com as “a breathless, blistering psychological thriller guaranteed to hold you captive…”, this book resonates with anyone whose boss is prone to use gaslighting techniques.
In EXPOSURE, Amy has crashed and burned. Newly out of rehab and with her career in tatters, she’s unwittingly plunged into a nightmare fraud investigation in which no one can be trusted and nothing is what it seems. Does she have the resilience to defeat her enemies and rebuild her life? This book has been hailed by Bestthrillers.com as one of the finest thrillers of 2017.
In RESTITUTION, we get to see Amy out of the office and on the loose in Prague, searching for long lost works of art. But she’s still the same Amy though, so it won’t be all plain sailing for her…
Further books are scheduled for publication in 2019 and beyond.